drugset / Trial / NCT04648813

Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses

NCT04648813

Phase 4 Completed 15 enrolled University of Saskatchewan
RandomizedCrossoverTriple-blindTreatment

Summary

The study will compare the effect of inhaled tiotropium versus placebo on allergen induced early asthmatic responses in individuals with atopic asthma.

Timeline

Start
2020-11-13
Primary completion
2021-04-20
Completion
2021-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 5 ug Inhaled

Indications